Gilder Gagnon Howe & CO LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Gilder Gagnon Howe & CO LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $12 Million - $21.1 Million	-144,476 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $12.6 Million - $16.3 Million	-114,021 Reduced 44.11%	144,476 $17.1 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $834,839 - $1.24 Million	8,371 Added 3.35%	258,497 $35.6 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $11,071 - $15,557	-112 Reduced 0.04%	250,126 $34.7 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $867,111 - $1.38 Million	-13,182 Reduced 5.0%	250,238 $24.3 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $10.4 Million - $14.9 Million	162,113 Added 160.02%	263,420 $18 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $30,192 - $45,583	-464 Reduced 0.46%	101,307 $8.68 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $34,302 - $45,288	-581 Reduced 0.57%	101,771 $6.62 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $5,598 - $14,326	193 Added 0.19%	102,352 $7.48 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $2.81 Million - $5.85 Million	102,159 New	102,159 $3.48 Million
Q4 2017 Jan 31, 2018	SELL	$20.44 - $35.56 $1.53 Million - $2.65 Million	-74,637 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$23.54 - $38.21 $1.76 Million - $2.85 Million	74,637	74,637 $2.79 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.